Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
The Lancet. Infectious Diseases
|
May 27, 2024
The long-term efficacy of a respiratory syncytial virus vaccine for older adults
Charles J Sande
The Lancet. Healthy Longevity
|
September 13, 2022
Development of a controlled human infection model to study respiratory syncytial virus infection in older adults
Charles J Sande
The Lancet. Infectious Diseases
|
May 9, 2021
Implementation strategies for passive respiratory syncytial virus immunisation
Charles J Sande
The Journal of Infection
|
June 26, 2017
Development of respiratory syncytial virus (RSV) vaccines for infants
Hannah E Gerretsen, Charles J Sande
Therapeutic Advances in Infectious Disease
|
April 2, 2016
Best practice in the prevention and management of paediatric respiratory syncytial virus infection
Simon B Drysdale, Christopher A Green, Charles J Sande
Vaccine
|
July 10, 2014
The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants
Charles J Sande, Patricia A Cane, D J Nokes
Therapeutic Advances in Infectious Disease
|
August 7, 2019
Respiratory syncytial virus: diagnosis, prevention and management
Rachael Barr, Christopher A Green, Charles J Sande, et al.
Expert Review of Vaccines
|
December 5, 2015
RSV vaccine use--the missing data
Simon B Drysdale, Charles J Sande, Christopher A Green, et al.
Interdisciplinary Topics in Gerontology and Geriatrics
|
April 20, 2020
Vaccination against Respiratory Syncytial Virus
Christopher A Green, Simon B Drysdale, Andrew J Pollard, et al.
Scientific Reports
|
September 16, 2018
Untargeted analysis of the airway proteomes of children with respiratory infections using mass spectrometry based proteomics
Charles J Sande, Martin Mutunga, Jacqueline Muteti, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
The Lancet. Infectious Diseases
|
May 27, 2024
The long-term efficacy of a respiratory syncytial virus vaccine for older adults
Charles J Sande
The Lancet. Healthy Longevity
|
September 13, 2022
Development of a controlled human infection model to study respiratory syncytial virus infection in older adults
Charles J Sande
The Lancet. Infectious Diseases
|
May 9, 2021
Implementation strategies for passive respiratory syncytial virus immunisation
Charles J Sande
The Journal of Infection
|
June 26, 2017
Development of respiratory syncytial virus (RSV) vaccines for infants
Hannah E Gerretsen, Charles J Sande
Therapeutic Advances in Infectious Disease
|
April 2, 2016
Best practice in the prevention and management of paediatric respiratory syncytial virus infection
Simon B Drysdale, Christopher A Green, Charles J Sande
Vaccine
|
July 10, 2014
The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants
Charles J Sande, Patricia A Cane, D J Nokes
Therapeutic Advances in Infectious Disease
|
August 7, 2019
Respiratory syncytial virus: diagnosis, prevention and management
Rachael Barr, Christopher A Green, Charles J Sande, et al.
Expert Review of Vaccines
|
December 5, 2015
RSV vaccine use--the missing data
Simon B Drysdale, Charles J Sande, Christopher A Green, et al.
Interdisciplinary Topics in Gerontology and Geriatrics
|
April 20, 2020
Vaccination against Respiratory Syncytial Virus
Christopher A Green, Simon B Drysdale, Andrew J Pollard, et al.
Scientific Reports
|
September 16, 2018
Untargeted analysis of the airway proteomes of children with respiratory infections using mass spectrometry based proteomics
Charles J Sande, Martin Mutunga, Jacqueline Muteti, et al.
Page
of 3